For all that’s worked in favor of marijuana stocks in recent years, there are plenty of risks. Some of these risks, such as profitability eluding most pot stocks, are readily apparent.
Tag Archives: companies
Legal marijuana may be a multi-billion dollar industry in Colorado, but cannabis is still illegal federally — so any job in the industry can be considered trafficking in a controlled substance.
Who gets to profit from Canada’s booming weed industry? Researchers at The Weekly found that nearly 40 former politicians and police officers are involved in medicinal marijuana companies, set to make retail sales as soon as it becomes legal.
Massachusetts’ legalization of recreational marijuana has created a cottage industry of companies selling the drug under the guise of giving it away for free, or pot “gifting.”
Canada’s No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country’s legalization of recreational marijuana use later this year.
Investors are betting Canada’s smaller financial firms could see a jump in revenues after they helped fund marijuana companies ahead of the country’s planned legalization of the drug this year.
Canadian marijuana producer Aurora Cannabis Inc (ACB.TO) is in talks with rivals CanniMed Therapeutics Inc (CMED.TO) and Newstrike Resources Ltd (HIP.V) to buy both businesses in a friendly deal that would create the nation’s top weed company, people familiar with the matter told Reuters on Friday.
Here’s Why Aurora Stock May Survive the Volatility. A simple case of acquisition has turned two marijuana companies—Aurora Cannabis Inc. (TSE: ACB), (OCTMKTS: ACBFF) and CanniMed Therapeutics Inc. (TSE: CMED), OCTMKTS: CMMDF)—into the biggest adversaries
A Canadian firm is launching an exchange-traded fund that gives investors exposure to the U.S. recreational marijuana market — a sector that’s been largely avoided by other ETFs because of legal uncertainties.
Aurora Cannabis Inc. (TSX:ACB) and Canopy Growth Corp. (TSX:WEED) are the two frontrunners in the rapidly emerging Canadian cannabis scene, but will these two powerhouses play leapfrog as legalization day comes and goes?
Alcohol companies beware: Cannabis startups are coming for your customers. Now that recreational marijuana is legal in California and seven other states, startups are vying with traditional beverage companies for the attention of consumers planning to ingest a social intoxicant.
Canadian cannabis stocks fell on Thursday after the U.S. government said it would resume enforcement of federal laws banning marijuana in states that had legalized pot, disrupting a seven-day rally that boosted shares to record highs.
Marijuana companies are higher than ever as California rolls toward recreational legalization. The BI Canada Cannabis Competitive Peers index is having its best day ever as Californians prepare to light up, or eat up, marijuana products starting Jan. 1 at 12 a.m.
Here’s why the marijuana market is so intriguing, how big the opportunity could be, and why these stocks are top stocks to own.
Local businesses are facing a dilema now that recreational marijuana is legal in Nevada. The question is, do they hire someone who uses the drug on their own time? Companies are being forced to review their policies.
A healthy day of trading for Canadian cannabis stocks led the North American Marijuana Index to gain several points over Monday’s 169.07 close.
The tiny village of Mount Orab and the city of Akron are among diverse locations of 12 large growers Ohio has picked for its medical marijuana program.
The Marijuana Index, which covers leading cannabis investments on both sides of the Canada-U.S. border, rose 7% on Monday to close at 174.82.
If it seems like there’s been a spurt of deals and potential deals going on in the cannabis industry lately, it’s because that’s exactly what’s happening.
With the state set to make medical marijuana available within weeks, two Maryland companies have formed a partnership to study how well vapor-inhalation devices work for patients.
A subsidiary of the New York Stock Exchange launches trading on Dec. 26 for its first-ever marijuana fund, a major step for an industry that’s struggled to access mainstream U.S. financial instruments, even as Canadian markets have kicked off marijuana investment.
In the business of medicinal marijuana, there are strains for almost anything that ails you. So far, though, female entrepreneurs have yet to find a variety that addresses a painful side effect of the booming legal pot industry: sexism.
At one point, MassRoots was flying high, raising millions of dollars from investors and attempting to become the first cannabis company listed on the Nasdaq.
Manitoba’s the latest province to unveil its plan for marijuana sales and distribution, releasing details Tuesday on how the new industry will operate.
Colorado cannabis companies have found it is hard for them to be charitable. Nonprofits often turn away pot profits for fear of losing federal grant money.
Marijuana stocks were down sharply in Tuesday’s trading as Toronto Stock Exchange operator TMX Group Limited suggested the exchange is going to start cracking down on marijuana producers engaging in illegal activities south of the border.
I had a chance to interview one of the cannabis industry movers, someone who has been involved in this industry for quite some time. She has co-founded several companies, had her hands in all different kinds of areas during these start-ups and finally through all of that has found her one true passion in the cannabis world. She is an cannapreneur that radiates energy and excitement!
Canada’s TMX Group Ltd (X.TO), operator of the Toronto Stock Exchange, said on Monday that it might delist stocks of marijuana companies with interests in the United States, where their operations are illegal under federal law.
Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.
Baltimore judge ruled Wednesday that a case that could disrupt Maryland’s fledgling medical marijuana industry should proceed to trial.
Commuters might catch a glimpse of the future out their car windows on Monday: the first Massachusetts billboard ads for a marijuana dispensary.
Bank of Montreal and Toronto-Dominion Bank are emerging as the banks of choice for Canada’s burgeoning marijuana industry, even as some lenders shun the sector.
Marijuana stock investors are going to have to keep their eyes on the following two critical data points for each and every marijuana stock they’re considering buying, or that they already own.
With recreational marijuana set to become legal in California in just a few months, this year’s Cannabis World Congress and Business Expo was bigger than ever.
Charity organizations are reluctant to take donations from cannabis companies, even if the state has legalized the industry. Organa Brands learned this the hard way.
At long last, Maryland’s first legal marijuana crop is growing. With 19 companies cleared to grow, process and sell the plant, the seeds of the medical marijuana program have literally been planted, four years after the state legalized cannabis for medical use.
It seems as though news of recalls related to specific batches of bad marijuana from licensed Canadian producers has been coming in more frequently than marijuana investors and consumers would like to see.
Despite missing a key state deadline earlier this month, three more medical marijuana growers won final licenses on Monday to cultivate the drug.
As more states legalize adult use marijuana, hemp CBD makers will find that they will need to make marijuana-derived products too if they want to succeed.
Medical cannabis companies and investors are calling on Gov. Greg Abbott’s office and the Department of Public Safety to approve more dispensary licenses beyond the three given provisional approval in May.
Any move by the Toronto Stock Exchange owner to stop settling trades for marijuana companies with U.S. operations would undermine the market’s regulatory system, according to one Canadian pot company.
There has been a lot of news in the marijuana industry this year. The medical marijuana industry exploded, and many new companies came to market in a frenzy, which reminded investors of the exciting technology bubble.
The legal sale of marijuana in Uruguayan pharmacies is facing challenges as banks refuse to deal with companies linked to the drug in order to follow international financial laws.
Canada’s TMX Group Ltd (X.TO) is seeking guidance from the country’s securities regulators, it said on Thursday, as it weighs how to deal with marijuana companies listed in Canada with interests in the United States, where the business remains federally illegal.
By all accounts, Eilon Bdil has no personal interest in marijuana. But as the business manager of Kibbutz Elifaz, he’s a big believer in the herb. Bdil sees medical marijuana as a unique opportunity to revive his remote Negev community.
Future medical marijuana growers and sellers in the Natural State can’t take their money to the bank, for now, that is. After doing his homework, the state lawmaker who crafted the new cannabis laws has learned more money, more problems when it comes to doing business without banking assistance.
If you look around, chances are you won’t find many marijuana stocks struggling. But there’s always an outlier — and for the marijuana industry that’s drugmaker Insys Therapeutics.
Maryland’s beleaguered medical marijuana industry faces a critical deadline Monday, when companies the state has selected to grow the plant are required to be operational.
TMX Group Ltd’s CEO on Thursday brushed off signs that the grip of Canada’s dominant stock exchange operator on overall trading volumes was slipping, saying recent market share losses were mostly due to its rejection of certain listings.
People growing their own marijuana is a significant concern to Big Pharma. As state legalization of cannabis-derivatives spreads, the drug companies contemplating the potential of medical marijuana see a threat from both homegrown and professionally harvested medical-grade marijuana.